logo
Cancer is on the rise in India: could air pollution be a factor?

Cancer is on the rise in India: could air pollution be a factor?

The Hindu03-06-2025
Over the past decade or so, air pollution has been increasingly spoken about in India, particularly in the context of the deterioration of air quality across large parts of the country, especially in the winter months. The air we breathe is known to be linked to respiratory illnesses and even cardiac disease, but now, experts say, there is also a strong association with a disease that is a rising burden in India: cancer.
The scale of the cancer burden in India
Cancer numbers are rising, and rising fast in India. The Indian Council of Medical Research-National Cancer Registry Programme has projected that the number of cancer cases in the country will spike from 14.6 lakh in 2022 to 15.7 lakh in 2025. Approximately one in nine people in India is expected to face a cancer diagnosis during their lifetime, the ICMR estimates.
Cancer ranks second when it comes to non-communicable diseases that cause deaths in India. Lung cancer is the second-most common cancer among men in India, and also figures amongst the top five when it comes to women. Globally, it is the leading cause of cancer-related deaths, accounting for the highest mortality rates among both men and women.
Over the past two decades, doctors say there has been a concerning pattern emerging in India: a rise in the number of non-smoking lung cancer cases.
Traditionally, lung cancer has always been associated with smoking (which continues to remain the major risk factor) and its incidence has always been lower in India, compared to the West, says Kumar Prabhash, head, solid unit medical oncology, at Tata Memorial Hospital, Mumbai. 'Smoking rates have always been higher in the West and lower in India, and this was reflected in the lung cancer numbers. A large number of cases were associated with smoking, both in the West and India, in the past. Now however, and this is what we have been seeing over the past several years, there is a marked difference: a significant proportion of the lung cancer cases in India are in never smokers,' he says.
Estimates vary, but several doctors agree that up to 30% of lung cancer cases that are now being seen are in those who have never smoked.
At the Cancer Institute, Adyar, Chennai, two separate studies, one from 2012 and one from 2017, reflected this trend. In the first study, says Arvind Krishnamurthy, head of surgical oncology at the institute, researchers analysed patient data from 258 cases between 2003 and 2007, and found nearly 40% of the patients were non-smokers. In the second study, analysing data from 495 patients who came in during 2014-15, the non-smoking cases were over 55%,' he says.
There are other factors that are also playing out in this pattern, the histology (the way cancer cells and tissues appear under a microscope) of the cancers for instance, is different: while most smokers present with squamous cell carcinoma, in non-smokers the usual presentation is adenocarcinoma, mirroring a global trend in the rise of adenocarcinoma, says Dr. Krishnamurthy.
Age-wise, as with all cancers, patients in India are about a decade younger than those in the West, says Dr. Prabhash. Another concerning factor is that among women, the non-smoking lung cancers are higher than in men.
The shift, doctors say, points to the urgent need to look beyond smoking and tobacco exposure for causes of lung cancer.
Could air pollution be behind the rise?
There is no doubt, says Krithiga Shridhar, head, Cancer Epidemiology Unit, Centre for Chronic Disease Control, New Delhi, that both outdoor (ambient) air pollution in general, and particulate matter (PM) in particular, are Group 1 carcinogens, meaning that there is sufficient evidence based on human studies that they have the potential to cause cancer. Indoor (household) air pollution, meanwhile, is classified as a group 2 carcinogen, meaning the evidence is probable.
According to Swiss tech company IQAir's 2024 World Air Quality Report, India ranked as the fifth-most polluted country in the world with an annual average PM 2.5 concentration of 50.6 micrograms per cubic metre, against the World Health Organization's recommendation of 5, and higher than India's National Ambient Air Quality Standards of 40.
'The causal links are very well established between air pollution and lung cancer. The majority of evidence, however, is from settings where air pollution is low. From India, the evidence is still emerging,' Dr. Krithiga says.
Doctors point out that while at present they can state that there is a strong association between air pollution and lung cancer, more definitive evidence is needed from the country to establish it as a cause.
A 2022 research paper in the Indian Journal of Medical Research that described the epidemiology, and clinical profile of lung cancers in India, based on data from the National Cancer Registry Programme also notes this trend, and the potential role of indoor and outdoor air pollution. 'Compared to GATS (Global Adult Tobacco Survey) -1 (2009-2010), the prevalence of tobacco use has decreased in GATS-2 (2016-2017). Hence, there is an increasing recognition of the role of air pollution in the causation of lung cancer. According to recent findings of the National Non-Communicable Disease Monitoring Survey, almost half (48.5%) of the adults reported exposure to second-hand smoke at home, workplace or travel,' the paper states.
Another contributor may be indoor (household) air pollution, particularly among women, say experts. The burning of solid fuels and biomass for cooking could be behind this. 'Even though the use of solid fuels for cooking has declined with most households switching to gas, their use in the past may be a factor, as lung cancer has a long latency period and generally presents a couple of decades after the exposure to the cause,' says Dr. Prabhash.
Even in the northeast, says Ravi Kannan, director, Cachar Cancer Hospital and Research Centre, Assam, where the burden of cancer overall is the highest in India and where tobacco and alcohol use are major risk factors, the etiology (cause) of lung cancers is beginning to change, reflecting the larger Indian trend. 'Tobacco continues to remain a major cause of lung cancers here, but this is slowly shifting. The Northeast has always been one of the cleanest regions of India, but air pollution is beginning to be felt here as well. Also, in tribal communities, the fire is always kept burning, which could be a contributing factor, and while these traditional ways of life are changing now, it will take time for the impact of the change to be felt,' he says.
Air pollution may not be the only factor however: a research paper published last year in The Lancet Regional Health - Southeast Asia, 'Uniqueness of lung cancer in Southeast Asia', states that occupational exposure to asbestos, chromium, cadmium, arsenic, coal-based products, as well as genetic susceptibility and pre-existing lung disease, could all be contributing, and these are all factors that need to be researched says Dr. Prabhash.
The challenges of diagnosis and treatment
Lung cancer has one of the highest mortality rates when it comes to cancers in India. Its diagnosis, however, is often late. Primarily, says Partha Pratim Medhi, assistant professor, radiation oncology, AIIMS Guwahati, this is because its symptoms are nonspecific – cough, chest pain and shortness of breath are seen with other conditions as well. 'Even in X-Rays, very few healthcare professionals will first suspect lung cancer,' he says. Dr. Prabhash adds that in India particularly, doctors are more prone to suspect tuberculosis first, potentially delaying the diagnosis.
The 2022 research paper states that 'close to half of the patients had a distant spread of disease at the time of presentation in our analysis. Similar findings have been reported by studies from other Indian settings where most of the patients had Stage IV disease at the time of diagnosis.'
Of 10 patients he sees in a month, says Dr. Medhi, there is perhaps one who has lung cancer that is in stage 1 or 2. Four are perhaps in stage 3, and the remaining five in stage 4. 'By this time the cancer has metastatised, spreading to the bones, brain, liver and other parts, which is why survival rates are low,' he says.
While diagnostic facilities have improved over the years, with molecular testing now available to identify genetic changes and biomarkers to help with treatment plans, the infrastructure, for the most part, is still in tier 1 and tier 2 cities, making access an issue, says Dr. Prabhash.
When it comes to treatment options too, most are available in India, but affordability remains a challenge. Immunotherapy, which has been showing promising results in lung cancer in other countries, is only partially available. 'Some of these drugs are approved in India, while others are not. But even the drugs that are approved are extremely expensive, putting them out of the reach of most people,' says Dr. Medhi.
The way forward
At present, the way air pollution is viewed is very narrow, says Abhishek Shankar, assistant professor, radiation oncology, AIIMS, Delhi. 'It is now emerging as a serious killer and should be viewed as such,' he points out. Currently, he says, India reports about 75,000 new cases of lung cancer each year, but this is projected to go up to 1 lakh cases, calling for urgent action.
Data, say doctors, is what is needed: more research from India about the causes of lung cancer beyond smoking. 'While tobacco and smoking continue to be major risk factors, the pattern that has emerged now is well established, and we need to utilise this to find the links to the causes. Remember, air pollution is not only a risk factor for lung cancer – there is evidence for it across cancer sites including oral and urological, as well as childhood leukaemia,' says Dr Krithiga.
In addition to extensive, India-based research into the links between air pollution and cancer, the country also needs measures to combat pollution, experts say.
There is a window of opportunity in the Northeast now, to prevent the hazards of environmental pollution, says Dr. Kannan. 'We can intervene now, with a concentrated effort from the government, non-governmental organisations and civil society. The Northeast can learn, and equip itself to be able to prevent, and better handle cases in the future,' he says.
When it comes to the rest of the country, household air pollution has been progressively declining in India. 'It has not been fully tackled, but we are making progress, especially with the provision of cleaner sources of fuel such as gas,' says Dr. Krithiga. Outdoor air pollution presents more of a challenge, she adds. 'The sources of outdoor pollution are multiple, and our handling of it needs to be multi-sectoral. We are at the stage of acknowledging and finding ways to address the problem. This is the way forward.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

No, COVID vaccines aren't killing young adults; The real threat is being ignored: Experts
No, COVID vaccines aren't killing young adults; The real threat is being ignored: Experts

Time of India

time3 hours ago

  • Time of India

No, COVID vaccines aren't killing young adults; The real threat is being ignored: Experts

New Delhi : Sudden deaths among young adults are being wrongly blamed on vaccines. Extensive data from ICMR and AIIMS confirms the real culprits: lifestyle, genetics, and undiagnosed heart conditions , inform medical experts. India's premier scientific institutions have firmly debunked the narrative linking COVID-19 vaccines to sudden cardiac deaths . Backed by research from ICMR, NCDC, and AIIMS, health experts are urging the public to move beyond vaccine blame and address the actual risk factors—undiagnosed cardiac issues, post-COVID complications, poor lifestyle habits, and genetic predispositions. 'The recent findings are timely and reassuring. Most sudden cardiac deaths occur due to pre-existing or lifestyle-related cardiac issues—not vaccines,' said Dr. Amit Bhushan Sharma, Director and Unit Head, Cardiologist, Paras Health, Gurugram. 'Vaccination is not the problem—neglected heart health is,' said Dr. Prabhat Ranjan Sinha, Senior Consultant, Internal Medicine, Aakash Healthcare. These comments come amid rising public anxiety around unexplained deaths among adults aged 18 to 45. The ICMR-NIE multicentric study, conducted from May to August 2023 across 47 hospitals in 19 states, analysed cases of healthy adults who died suddenly between October 2021 and March 2023. The study found no increased risk of sudden death linked to COVID-19 vaccination. Complementing the ICMR-NIE findings, an ongoing AIIMS-led prospective study has identified myocardial infarction (heart attacks) as the leading cause of such deaths, with genetic mutations noted in some unexplained cases. Importantly, no significant deviation from pre-pandemic mortality patterns has emerged. 'When people hear of sudden deaths in the young, they panic. But attributing them to vaccines without evidence only spreads fear,' said Dr. Praveen Gupta, Chairman, Marengo Asia International Institute of Neuro and Spine. 'The data is clear—there is no causal link. Awareness, early diagnosis, and mental well-being must now be our focus.' Experts clarified that typical post-vaccination symptoms such as mild fever, fatigue, or muscle aches are short-lived and unrelated to cardiac functioning. 'These symptoms are completely different from true cardiac red flags like chest pain, palpitations, or fainting,' Dr. Sharma emphasised. The findings stress the urgent need for preventive cardiac screening, particularly in individuals with sedentary lifestyles, high stress levels, or a family history of heart disease. 'Vaccines have passed rigorous trials and regulatory scrutiny. Sudden cardiac deaths are multifactorial—but COVID-19 vaccination is not among the contributing factors,' reiterated Dr. Sinha. The Union Health Ministry, in a statement, reaffirmed its commitment to evidence-based public health communication and warned against misinformation that could undermine trust in future immunisation efforts. Experts are calling for responsible communication and increased awareness around early signs of heart disease to prevent further loss of life and public panic.

23 deaths in 40 days: Karnataka's heart attack cases fuel COVID-19 vaccine fears, but ICMR finds no link; here's what experts say
23 deaths in 40 days: Karnataka's heart attack cases fuel COVID-19 vaccine fears, but ICMR finds no link; here's what experts say

Time of India

time4 hours ago

  • Time of India

23 deaths in 40 days: Karnataka's heart attack cases fuel COVID-19 vaccine fears, but ICMR finds no link; here's what experts say

Heart attack-related deaths have suddenly spiked at an alarming rate in Karnataka's Hassan district, as 23 people among the young and middle-aged groups have died after suffering heart attacks in the last 40 days. The shocking report left Karnataka Chief Minister Siddaramaiah questioning whether there could be a link between these deaths and the COVID-19 vaccine. Following the incident, the chief minister formed a team of experts, led by Dr. Ravindranath from the Jayadeva Institute, to find out what could be the cause behind the spike in heart attack deaths. On the other hand, another troubling concern is the age group, as most of them were young or middle-aged people. The Ministry of Health and Family Welfare on Wednesday clarified that no link has been found between the COVID-19 vaccines and the surge in sudden deaths due to heart attacks. In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously. To identify the exact cause of these series of deaths and to find solutions, a committee of experts has been… ICMR and AIIMS studies find no link between the COVID-19 vaccine and heart attacks The health ministry cited extensive studies conducted by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences (AIIMS) on the sudden deaths among adults. Issuing a statement, the ministry noted, 'Extensive studies by ICMR (Indian Council of Medical Research) and AIIMS on sudden deaths among adults post-COVID have conclusively established no linkage between COVID-19 vaccines and sudden deaths. Studies by ICMR and the National Centre for Disease Control (NCDC) have affirmed that COVID-19 vaccines in India are safe and effective, with extremely rare instances of serious side effects." Heart attacks, or myocardial infarctions, can occur in individuals who appear healthy, often due to a combination of underlying factors that may not be immediately evident. In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously. To identify the exact cause of these series of deaths and to find solutions, a committee of experts has been… Can COVID-19 vaccines trigger heart attacks among young adults? Research by the Indian Council of Medical Research (ICMR) and AIIMS found no direct link between COVID-19 vaccines and the recent surge in sudden cardiac deaths. 'An analysis of 250 heart attack-related deaths in India ruled out vaccines as a primary cause, consistent with global data from the CDC and WHO. COVID-19 infection itself poses a higher risk of heart complications, with infection-related myocarditis being 5-15 times more common than vaccine-related cases. Vaccination reduces the risk of severe COVID-19, indirectly protecting against heart damage,' says Dr. Basavaraj Utagi, Senior Consultant Cardiology, Fortis Hospital Cunningham Road. Lifestyle factors play a major role A major contributing factor is atherosclerosis, a condition in which plaque accumulates in the arteries, leading to narrowing and reduced blood flow to the heart. 'This can occur even in individuals who appear healthy, as underlying issues like high cholesterol or elevated blood pressure may go undetected,' explains Dr. Rahul Gupta, Director of Cardiology at Gleneagles Hospital Parel. According to Dr. Utagi, 'Lifestyle factors are likely contributing to the spike in cardiac deaths, including psychosocial stress, unhealthy diets, lack of physical activity, smoking, and pollution exposure. Urbanisation has increased access to processed foods, leading to obesity, diabetes, and high cholesterol.' Rapid urbanisation has exposed a significant proportion of India's population to these risk factors, increasing heart disease risk. 'Chronic stress from fast-paced urban life also elevates cortisol and blood pressure. These factors, rather than vaccines, are likely driving the surge in cardiac problems and deaths,' he adds. COVID-19 vaccines and heart health Vaccination remains crucial in preventing severe COVID-19 and its complications. Addressing lifestyle factors and urbanisation-related health risks is essential to mitigating the cardiac disease burden. 'Heart attacks can occur in seemingly healthy people due to various factors such as atherosclerosis, stress, genetics, lifestyle habits, and hidden medical conditions. Staying informed about your health and having regular medical check-ups are key to prevention,' advises Dr. Gupta.

Dengue vaccine a step closer? India's first phase 3 trial hits 50% enrolment mark, early data shows no safety concerns
Dengue vaccine a step closer? India's first phase 3 trial hits 50% enrolment mark, early data shows no safety concerns

Indian Express

time4 hours ago

  • Indian Express

Dengue vaccine a step closer? India's first phase 3 trial hits 50% enrolment mark, early data shows no safety concerns

India has reached the 50 per cent enrolment mark in its first phase III clinical trial for the indigenous tetravalent dengue vaccine, DengiAll, with over 7,000 participants randomised across 20 trial sites. Initial results show no safety concerns for the one-shot vaccine to fight the mosquito-borne viral disease, according to researchers. Developed by Panacea Biotec Limited under a licensing agreement with the National Institutes of Health (NIH), the primary US federal agency for biomedical research, DengiAll targets all four dengue virus subtypes and has shown promising results in earlier clinical trials. What is the dengue vaccine DengiAll about? DengiAll has a weakened form of all four dengue virus subtypes and has the same virus composition as the vaccine developed by NIH, except for the inactive ingredients. The NIH also evaluated the vaccine in the US and the results were found to be promising in the early-stage clinical studies. A Phase I and II clinical trial conducted in India revealed a balanced and robust immune response across all four dengue virus types. The vaccine was also found to be safe and well-tolerated. Multiple ICMR institutes are involved in the study to evaluate the efficacy, immunogenicity and safety of DengiAll. The ICMR-National Institute of Translational Virology (NITVAR) and AIDS Research (formerly ICMR-NARI) is responsible for overall trial coordination. Dr Sheela Godbole, director, ICMR-NITVAR and national principal investigator of the trial, told The Indian Express that the follow-up will be completed in the last quarter of 2027. According to Dr Abhijit Kadam, national co-principal investigator, healthy adults in the 18-60 year age group are being screened and randomised to receive either the dengue vaccine or a placebo (2:1). 'They will be followed up for two years,' he said. Dr Suchit Kamble, principal investigator for the NITVAR clinical trial site, explains that the vaccine would help in prevention of a disease that has no treatment. 'Some of the infections could result in severe manifestations like bleeding and sudden drop in blood flow and may threaten the life of the patient,' he said. The 20 trial sites are located in the following cities: Chennai, Pune (with two sites), Mysuru, Hyderabad, Puducherry, Kochi, Jodhpur, Ranchi, Kolkata, Aligarh, Patna, Rohtak, Ludhiana, Bengaluru, New Delhi, Bhubaneswar, Rishikesh, Guwahati, and Faridabad. The research teams at these sites come from well-known medical institutions, including three affiliated with ICMR. Dengue fever is one of the top 10 threats to global health, according to the World Health Organisation (WHO). India accounts for a large fraction of global dengue cases and the disease is endemic (regularly occurring within an area or community) in certain regions. Data from the National Centre for Vector Borne Diseases Control, Ministry of Health and Family Welfare, shows that till March this year, around 12,043 dengue cases were reported, while 2.3 lakh cases and 297 deaths were reported in 2024. Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition. ... Read More

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store